New hope for bladder cancer patients: chemo-immunotherapy combo targets tough tumors
Disease control
Not yet recruiting
This study tests a combination of two chemotherapy drugs placed directly into the bladder plus an immunotherapy drug given through a vein for people with high-risk non-muscle invasive bladder cancer that did not respond to or cannot receive standard BCG therapy. The goal is to se…
Phase: PHASE2 • Sponsor: BLATAM • Aim: Disease control
Last updated May 22, 2026 13:54 UTC